Industry Reports

japan-worlds-most-ambivalent-pharma-market

Japan The World's Most Ambivalent Pharma Market

25/06/2019
This report highlights trends in Japan’s pharmaceutical market, notably how costly, long-listed products will be replaced due to generic and biosimilar industries continuing to grow in volume and...
industry-report-2018

Annual Industry Report 2018

21/12/2018
The CPhI Annual Report is a comprehensive and critically important publication that analyses key trends and innovations forecast by our panel of world class experts. Running as a series of opinions...
Japan Report | 2018 - a big year for Japanese pharma

Japan Report | 2018 - a big year for Japanese pharma

28/11/2018
Japan has the world’s third largest pharma industry. Yet, for many international companies the market has not proved easy to access. Very high barriers to entry have combined with a historically...
biolive-opposite-attract

Opposites Attract - Small & Large Molecules

01/10/2018
Opposites attract Blurring the lines between small and large molecule manufacturing _____________________________________________________ The biopharmaceutical industry has grown impressively in...
market-prognosis-spain

IQVIA™ MARKET PROGNOSIS 2018-2022 | Spain

01/10/2018
FOREWORD IQVIA and CPhI are pleased to bring you our special Market Prognosis report sharing our view of the future of the Spanish pharma market. Both CPhI and IQVIA consider that such information is...
biopharma-news-india

A BioWorld special report

01/10/2018
Biopharma news and views for CPhI India From clinical trials to dealmaking to biosimilars launches, the biopharma landscape grows increasingly global. From the publishers of BioWorld, a Clarivate...